Ansichten-Navigation

Veranstaltung Ansichten-Navigation

Heute

What is Enough… Women in Clinical Trials?

Online

On May 16, 2018 from 1:00 pm - 2:30 pm (Eastern Daylight Time EDT), join the FDA Office of Women’s Health for The Great Debate! Featuring Ellis F. Unger, M.D., FDA CDER, and Rita F. Redberg, M.D., M.Sc., F.A.C.C. The debate centers on cardiovascular disease clinical trials and the challenges and complexity of the question […]

Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender

FDA White Oak Campus, Bldg. 31, Great Room FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503-A), Silver Spring, MD 20993, Vereinigte Staaten

Sex differences may influence susceptibility to substance use disorders, which could have implications for optimal prevention and treatment. Gender influences also impact public health by influencing  rescription rates, care, and treatment-seeking behaviors. To identify and treat at-risk women, researchers, educators, and clinicians must be able to recognize and consider sex and gender differences in substance […]